Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

MiNK Therapeutics, Inc. Common Stock (INKT)

Biological Products, (no Disgnostic Substances)

https://www.minktherapeutics.com

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.

149 FIFTH AVENUE, SUITE 500
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/15/2021

Market Cap

32,948,424

Shares Outstanding

34,520,000

Weighted SO

34,519,540

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

AFMD --.--%

IMGN --.--%

ADAP --.--%

SGMO --.--%

DAWN --.--%

ABOS --.--%

XFOR --.--%

INZY --.--%

VECT --.--%

Beta

0.0670

Last Div

0.0000

Range

0.75-1.9

Chg

0.0123

Avg Vol

64254

Mkt Cap

32948424

Exch

NASDAQ

Country

US

Phone

212 994 8250

DCF Diff

0.7353

DCF

0.0980

Div Yield

0.0000

P/S

-0.0028

EV Multiple

-1.6256

P/FV

-1.8672

Div Yield %

0.0000

P/E

-1.8110

PEG

-0.1489

Payout

0.0000

Current Ratio

0.9336

Quick Ratio

0.9336

Cash Ratio

0.9178

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.2237

CCC

-0.2237

Gross Margin

1.4462

Op Margin

0.0015

Pretax Margin

0.0015

Net Margin

0.0015

Eff Tax Rate

0.0063

ROA

-1.6555

ROE

0.9978

ROCE

-99.0424

NI/EBT

1.0000

EBT/EBIT

0.9791

EBIT/Rev

0.0015

Debt Ratio

0.4268

D/E

-0.2658

LT Debt/Cap

-0.3620

Total Debt/Cap

-0.3620

Int Coverage

0.1039

CF/Debt

-2.7414

Equity Multi

-0.6228

Rec Turnover

0.0000

Pay Turnover

1631.3165

Inv Turnover

0.0000

FA Turnover

-13775.0404

Asset Turnover

-1134.1193

OCF/Share

-0.3252

FCF/Share

-0.3238

Cash/Share

0.2508

OCF/Sales

0.0010

FCF/OCF

0.9958

CF Coverage

-2.7414

ST Coverage

0.0000

CapEx Coverage

-239.0824

Div&CapEx Cov

-239.0824

P/BV

-1.8672

P/B

-1.8672

P/S

-0.0028

P/E

-1.8110

P/FCF

-2.7394

P/OCF

-2.5626

P/CF

-2.5626

PEG

-0.1489

P/S

-0.0028

EV Multiple

-1.6256

P/FV

-1.8672

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 20, 07:30 ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

Revenue Product Segmentation